Arizona Medical Cannabis Exits 280E After Federal Rescheduling, June 2026
Arizona’s medical cannabis market just shifted under its feet. The Schedule III rescheduling of state-licensed medical marijuana took legal effect April 28, removing Section 280E for state-licensed medical licensees while leaving adult-use businesses untouched. Phoenix kept its local approval engine running in June, greenlighting a new dispensary at 1701 N. 99th Avenue and queuing three annual reviews, and the state’s top operators gathered in Paradise Valley to take stock of a maturing, consolidated market.
Top Headlines This Month
- 📋 Phoenix Board of Adjustment approves 99th Avenue dispensary permit
- 🏛️ Three medical marijuana reviews set for June 11 hearing
- ⚖️ Federal final order moves state-licensed medical marijuana to Schedule III
- 📊 2026 IEC Awards reflect Arizona cannabis market maturation
📋 PHOENIX: BOARD OF ADJUSTMENT APPROVES DISPENSARY USE PERMIT AT 1701 N. 99TH AVE
The Phoenix Board of Adjustment voted 5-2 on June 4, 2026, to uphold the Zoning Adjustment Hearing Officer’s decision and approve a use permit and variances for a medical marijuana dispensary at 1701 North 99th Avenue. The application (ZA-124-26-5), brought by Michelle Green of Lazarus and Silvyn P.C. on behalf of owner Arvin Saloum of Ninety-Nine Holdings LLC, included approval for the dispensary use in a C-2 zone, a variance to allow the facility within 500 feet of a residentially zoned district, and three additional variances reducing landscape setbacks and parking requirements. The board attached seven stipulations to the approval: the applicant must obtain an Arizona Department of Health Services certificate within 18 months or face a revocation hearing, must apply for building permits within one year, and must install and maintain an odor control system within one year. The applicant is also required to submit a security plan to the Planning and Development Department and notify the area Police Precinct Commander in writing. Board members Graham and Manoil dissented.
The approval at 1701 North 99th Avenue shows Phoenix’s Board of Adjustment granting a dispensary permit in a commercial zone where separation variances were needed, while attaching concrete compliance deadlines. The 18-month ADHS certificate requirement and the one-year odor control deadline give the approval clear expiration triggers if the licensee does not follow through.
🏛️ PHOENIX: ZONING ADJUSTMENT HEARING OFFICER AGENDAS THREE MEDICAL MARIJUANA REVIEWS FOR JUNE 11
The City of Phoenix Zoning Adjustment Hearing Officer scheduled a public meeting on June 11, 2026, at Phoenix City Hall (200 West Washington Street, Assembly Room C) to consider ten zoning applications, three of which involve medical marijuana facilities. Application ZA-261-18-2 is a one-year use permit review for a medical marijuana dispensary at 1720 East Deer Valley Drive, Suite 101, with Organica Patient Group Inc. as the applicant. Application ZA-243-19-5 is a one-year review for a nonprofit medical marijuana dispensary at 2601 West Dunlap Avenue (Greens Goddess Products, Inc., doing business as Key Cannabis), seeking variances for separation from another medical marijuana facility within 5,280 feet and from a residentially zoned district within 500 feet. Application ZA-239-20-4 is a one-year review for a medical marijuana cultivation and infusion facility at addresses on North 30th Avenue (ACP Real Estate LLC), seeking variances for separation from another medical marijuana facility within 5,280 feet and from a school within 1,320 feet.
All three cannabis applications are annual reviews of existing use permits, not new license requests, meaning they represent Phoenix’s ongoing oversight process for already-operating facilities. The separation variance renewals at the Dunlap Avenue dispensary and the North 30th Avenue cultivation and infusion site show that facilities operating under previously granted variances must continue to defend those exceptions on a recurring basis.
⚖️ FEDERAL: FINAL ORDER MOVES STATE-LICENSED MEDICAL MARIJUANA TO SCHEDULE III
On April 22, 2026, Acting Attorney General Todd Blanche signed a final order rescheduling two categories of marijuana from Schedule I to Schedule III of the Controlled Substances Act. The order was published in the Federal Register on April 28, 2026, the date it took legal effect. It covers FDA-approved marijuana drug products and marijuana subject to a qualifying state-issued medical marijuana license. Recreational and adult-use cannabis, along with synthetically derived THC, remain Schedule I. The order was issued without the standard notice-and-comment process, citing U.S. obligations under the United Nations Single Convention on Narcotic Drugs. For state-licensed medical marijuana businesses, the order removes the Section 280E deduction disallowance that previously barred them from deducting ordinary and necessary business expenses, though the order expressly notes it does not constitute a final determination on federal tax liability for any particular business. The order also creates an expedited DEA registration pathway for those licensees, though imports and exports of rescheduled products still require a permit. This action is limited to the two medical categories. A separate administrative hearing is scheduled for June 29, 2026, to consider whether all marijuana, beyond the two categories covered by this order, should move to Schedule III as well.
Arizona medical marijuana licensees now operate under a meaningfully different federal tax posture, with 280E no longer applying to their operations. Recreational cannabis businesses in Arizona are not affected by this change and remain subject to 280E restrictions. The June 29 hearing will determine whether that same relief extends to the adult-use side of the market.
📊 ARIZONA: 2026 INFLUENTIAL EXECUTIVES OF CANNABIS AWARDS REFLECT MARKET MATURATION
Arizona’s cannabis industry gathered at El Chorro Lodge in Paradise Valley for the 2026 Arizona Influential Executives of Cannabis (IEC) Awards, presented by Proven Media, CannaPac, and RW Navis and Associates. Honorees were selected by an expert panel based on market impact, operational excellence, and long-term stewardship rather than popularity. Executives from companies including Mint Cannabis, Story Cannabis, Copperstate Farms, The Pharm and Sunday Goods, BEST Dispensary, OGeez!, Baked Bros, Mohave Cannabis Co., and Green Pharms Dispensaries were among those recognized. A consistent theme across the event was the shift away from rapid early-stage growth toward disciplined operations, tighter compliance, and supply chain management. Multiple executives cited the June 2026 federal rescheduling hearing as a significant near-term development, focusing specifically on whether Section 280E relief would extend to adult-use operators and what that means for cash flow, margin, and access to traditional financing. Marie Saloum of Green Pharms Dispensaries noted she entered the Arizona market and has since moved from a technical operational focus to a community-driven retail model emphasizing consumer education.
The IEC event captures where Arizona’s cannabis retail market stands heading into the second half of 2026: a consolidated, competitive environment where the businesses still standing are those that built durable infrastructure during years of tight federal tax constraints. With medical 280E relief already in effect and a federal hearing scheduled for June 29 to consider extending Schedule III to the rest of the market, those businesses have a concrete reason for optimism.
Source:
https://azbigmedia.com/business/here-are-the-2026-arizona-influential-executives-of-cannabis/
The Bottom Line
Arizona’s medical cannabis sector is operating under its biggest federal tax shift in years, with Schedule III rescheduling ending 280E for state-licensed medical licensees as of April 28 while recreational businesses keep waiting on the June 29 hearing. Phoenix continued steady local oversight through new approvals and annual variance reviews, and the IEC Awards confirmed that the businesses still standing built durable infrastructure during the tight federal tax years.
📬 Get Monthly Market Updates
Stay ahead of the curve with our monthly cannabis retail market newsletter. New markets, regulatory changes, and expansion opportunities delivered to your inbox.
